Announcements Trials
Browse Landscape

Phase

Phase 2 76Phase 3 16Phase 1 7Phase 2/3 6Phase 1/2 5Phase NA 4Phase 4 3

Status

Completed 3Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Genitourinary 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Solid Tumors 1Neoplasms 1Advanced and/or Metastatic Solid Tumours 1Advanced Esophageal 1Advanced Cancer 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 1 × nimotuzumab × Clear all
NCT07053735 2025-07-08

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Peking University First Hospital

Phase 1 Not yet recruiting
30 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT02947386 2023-10-05

Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 1 Completed
7 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03554889 2018-06-13

Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells

Hangzhou Cancer Hospital

Phase 1 Unknown
21 enrolled

Advanced Cancer

NCT00950417 2015-08-19

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Biotech Pharmaceutical Co., Ltd.

Phase 1 Completed
11 enrolled
Gastrointestinal

Advanced Esophageal

NCT00985998 2015-08-19

Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer

Biotech Pharmaceutical Co., Ltd.

Phase 1 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02395068 2015-08-19

Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors

Biotech Pharmaceutical Co., Ltd.

Phase 1 Unknown
40 enrolled
Other solid neoplasm

Solid Tumors

NCT00369252 2007-02-28

Phase I Study of Nimotuzumab in Solid Tumours

YM BioSciences

Phase 1 Completed
18 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡